Susquehanna International Group, LLP Infinity Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 16, 2023	SELL	$0.16 - $0.74 $1,840 - $8,510	-11,500 Reduced 28.61%	28,700 $4,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $18,492 - $48,642	-40,200 Reduced 50.0%	40,200 $22,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $2,773 - $7,990	-4,700 Reduced 5.52%	80,400 $96,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.